butylscopolammonium bromide has been researched along with Disease Models, Animal in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Campos, A; Cechinel Filho, V; Jesuíno, FWDR; Pastor, MVD; Quintão, NLM; Reis, JP; Whitaker, JCP | 1 |
| Arihiro, S; Hashimoto, H; Kato, T; Okabe, M; Saijo, H; Tajiri, H; Tatsumi, N | 1 |
| Francisco, FA; Franco, CC; Gomes, RM; Malta, A; Martins, IP; Mathias, PC; Miranda, RA; Natali, MR; Oliveira, JC; Palma-Rigo, K; Pavanello, A; Prates, KV; Previate, C; Ribeiro, TA; Souza, AA; Tófolo, LP | 1 |
| Boatwright, CE; Fubini, SL; Goossens, L; Grohn, YT | 1 |
| Maitai, CK; Munenge, RW; Njoroge, DK | 1 |
1 trial(s) available for butylscopolammonium bromide and Disease Models, Animal
| Article | Year |
|---|---|
A comparison of N-butylscopolammonium bromide and butorphanol tartrate for analgesia using a balloon model of abdominal pain in ponies.
Topics: Abdominal Pain; Analgesics, Opioid; Animals; Butorphanol; Butylscopolammonium Bromide; Catheterization; Colic; Disease Models, Animal; Female; Horse Diseases; Horses; Male; Parasympatholytics | 1996 |
5 other study(ies) available for butylscopolammonium bromide and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Effect of Synadenium grantii and its isolated compound on dysmenorrhea behavior model in mice.
Topics: Animals; Butylscopolammonium Bromide; Disease Models, Animal; Dysmenorrhea; Edema; Euphorbia; Female; Ibuprofen; Mice; Phytotherapy; Plant Extracts | 2019 |
Microangiopathy triggers, and inducible nitric oxide synthase exacerbates dextran sulfate sodium-induced colitis.
Topics: Actins; Animals; Antibodies, Monoclonal, Humanized; Bevacizumab; Butylscopolammonium Bromide; Capillaries; Capillary Permeability; Colitis; Colon; Dextran Sulfate; Disease Models, Animal; Enteric Nervous System; Hypoxia-Inducible Factor 1, alpha Subunit; Intestinal Mucosa; Male; Mice, Inbred C57BL; Microcirculation; Nitric Oxide Synthase Type II; Peripherins; Platelet Endothelial Cell Adhesion Molecule-1; Vascular Endothelial Growth Factor A | 2015 |
Neonatal treatment with scopolamine butylbromide prevents metabolic dysfunction in male rats.
Topics: Animals; Animals, Newborn; Butylscopolammonium Bromide; Disease Models, Animal; Female; Male; Metabolic Diseases; Obesity; Rats; Rats, Wistar | 2016 |
A comparative study of two antispasmodic products: Buscopan and NO-Spa.
Topics: Animals; Butylscopolammonium Bromide; Disease Models, Animal; Guinea Pigs; Ileal Diseases; Papaverine; Parasympatholytics; Scopolamine Derivatives; Spasm | 1985 |